SPL Medical is pointing out a powerful publication in European Urology Focus

SPL Medical is pointing out a powerful publication in European Urology Focus

SPL Medical is pointing out a powerful publication in European Urology Focus highlighting the useability of Ferrotran® (Ferumoxtran) for MR-Angiography (MRA) even in renally impaired patients thus providing access to another market of approx. 1.5 bln USD with high growth rates.

No Comments

Sorry, the comment form is closed at this time.